SIRT1 and lung carcinoma: Earlier studies identified tumor suppressor p53 as the first nonhistone SIRT1 deacetylase target: under stress conditions, such as DNA damage, the deacetylation of p53 attenuates its transactivation-dependent apoptosis, thus promoting lung cancer cell survival [7, 8].